Serdar Madendere
6PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 06, 2025
Are NCCN and EAU Active Surveillance Criteria Reliable in Patients With ISUP Grade-2 Intermediate-Risk Prostate Cancer? A Novel Model Integrating MRI to Predict Adverse Pathology.Serdar Madendere, Barış Esen, Umut Can Karaarslan
|Aug 14, 2024
Can the Briganti 2019 nomogram be modified to predict lymph node metastasis risk in patients with prostate cancer detected with in-bore biopsy?Serdar Madendere, Mert Kılıç, Bengi Gürses
|Jun 26, 2024
Natural history of histologically benign PIRADS 4-5 lesions in multiparametric MRI: Real-life experience in an academic center.Serdar Madendere, Mert Kilic, Hatice Zoroglu
|Jan 03, 2023
The role of the size and number of index lesion in the diagnosis of clinically significant prostate cancer in patients with PI-RADS 4 lesions who underwent in-bore MRI-guided prostate biopsy.Mert Kilic, Serdar Madendere, Metin Vural
|Mar 29, 2022
Global Web Trends Analysis of Minimally Invasive Urinary Stone Treatment in the Last Decade and During the COVID-19 Pandemic.Serdar Madendere, Müslim Doğan Değer, Tevfik Aktoz
Pageof 1